Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Johnson Chemical Pharmaceutical Works Co Dividend Yield %?
Johnson Chemical Pharmaceutical Works CoROCO:4747 77 Dividend Yield % is 2.10% as of Jul. 15, 2026, which is 52% below its 10-year median of 4.41. GuruFocus rates ROCO:4747 with a GF Score™ of 77/100 and a GF Value™ of NT$60.21 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 515 Drug Manufacturers companies, Johnson Chemical Pharmaceutical Works Co ranks better than 53.59% on this metric.
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Johnson Chemical Pharmaceutical Works Co is 1.50, which seems too high.
During the past 12 months, Johnson Chemical Pharmaceutical Works Co's average Dividends Per Share Growth Rate was 16.80% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 10.00% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 0.90% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was -0.50% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Johnson Chemical Pharmaceutical Works Co was 55.50% per year. The lowest was -5.70% per year. And the median was 7.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Johnson Chemical Pharmaceutical Works Co (ROCO:4747) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Johnson Chemical Pharmaceutical Works Co Dividend Yield % Chart
Johnson Chemical Pharmaceutical Works Co Annual Data
ROCO:4747 vs ZTS, UTHR: Dividend Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Johnson Chemical Pharmaceutical Works Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Johnson Chemical Pharmaceutical Works Co Dividend Yield % vs Drug Manufacturers Industry
Johnson Chemical Pharmaceutical Works Co Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Johnson Chemical Pharmaceutical Works Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
TWD 1.050000
2026-07-06
2026-07-07
2026-07-29
Cash Dividend
annually
TWD:TWD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Johnson Chemical Pharmaceutical Works Co (ROCO:4747) has a Dividend Yield % of 2.10% as of Jul. 15, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Johnson Chemical Pharmaceutical Works Co and its competitors. This is 52% below median its historical median of 4.41. Over the past decade, Johnson Chemical Pharmaceutical Works Co's Dividend Yield % has ranged from 1.31 to 6.09. According to the industry distribution chart, Johnson Chemical Pharmaceutical Works Co ranks #239 out of 515 companies in the Drug Manufacturers industry, placing it in the top 46.4%.
Is Johnson Chemical Pharmaceutical Works Co's Dividend Yield % too high?
Johnson Chemical Pharmaceutical Works Co's current Dividend Yield % of 2.10% is 52% below median its 10-year median of 4.41. Over the past 10 years, this metric has ranged from a low of 1.31 to a high of 6.09. The Drug Manufacturers industry median Dividend Yield % is 1.93. Johnson Chemical Pharmaceutical Works Co's value of 2.10% is 8.8% above this industry median. Based on the distribution chart, Johnson Chemical Pharmaceutical Works Co ranks #239 out of 515 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Johnson Chemical Pharmaceutical Works Co has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Johnson Chemical Pharmaceutical Works Co's Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Johnson Chemical Pharmaceutical Works Co ranks #239 out of 515 companies for Dividend Yield %. This puts Johnson Chemical Pharmaceutical Works Co in the upper half of its industry. The industry median Dividend Yield % is 1.93. Johnson Chemical Pharmaceutical Works Co's value of 2.10% is 8.8% above this benchmark. Historically, Johnson Chemical Pharmaceutical Works Co's own Dividend Yield % has ranged from 1.31 to 6.09 over the past decade. While the company's 10-year median is 4.41 vs. the industry median of 1.93, Johnson Chemical Pharmaceutical Works Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 1.93, based on 515 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Johnson Chemical Pharmaceutical Works Co's current Dividend Yield % of 2.10% is 8.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Johnson Chemical Pharmaceutical Works Co and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 1.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Johnson Chemical Pharmaceutical Works Co's current Dividend Yield % is 2.10%, which is 52% below median its own 10-year median of 4.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Johnson Chemical Pharmaceutical Works Co stock overvalued right now?
Based on GuruFocus' analysis, Johnson Chemical Pharmaceutical Works Co (ROCO:4747) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$60.21, compared to a current price of NT$49.95 — trading 17% below its estimated fair value. The current Dividend Yield % is 2.10%, which is 52% below median its 10-year median of 4.41 and 8.8% above the Drug Manufacturers industry median of 1.93. Johnson Chemical Pharmaceutical Works Co's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Johnson Chemical Pharmaceutical Works Co (ROCO:4747), the current Dividend Yield % is 2.10% as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Johnson Chemical Pharmaceutical Works Co (ROCO:4747) Overvalued in 2026?
Based on GuruFocus' analysis, Johnson Chemical Pharmaceutical Works Co stock appears to be undervalued.
The current stock price of NT$49.95 is trading 17% below its estimated GF Value™ of NT$60.21.
GuruFocus considers Johnson Chemical Pharmaceutical Works Co to be Modestly Undervalued.
Key valuation signals for ROCO:4747:
Dividend Yield %: 2.10% (52% below median its 10-year median of 4.41)
GF Value™: NT$60.21 vs. price of NT$49.95 (17% below fair value)
Industry Position: 8.8% above the Drug Manufacturers median (#239 of 515)
No single metric tells the full story. See the ROCO:4747 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Johnson Chemical Pharmaceutical Works Co Business Description
Johnson Chemical Pharmaceutical Works Co is engaged in the manufacturing of pharmaceutical ingredients, importing and selling pharmaceutical materials and products. It manufactures drugs in a variety of forms, including solid dosage forms, capsules (soft/hard), tablets (sugar/film-coated), powder and granule, as well as nasal sprays. It offers products in therapeutic areas including the central nervous system, respiratory, cardiovascular, gastrointestinal, and endocrine system, vitamins, anti-inflammatory, cough and cold, and pain relievers. Its revenue mainly comes from medical product sales.
77GF Score
Get the complete analysis for ROCO:4747
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4747 has been successfully added to your 
